Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

Xu Yang, Haitao Zhao, Jiamin Cheng et al.|Hepatology International|2023

Cited by 60